Author's Reply to Joerg Putzke et al. Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database"
- PMID: 33860920
- DOI: 10.1007/s40259-021-00474-x
Author's Reply to Joerg Putzke et al. Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database"
Comment on
-
Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database".BioDrugs. 2021 May;35(3):373-374. doi: 10.1007/s40259-021-00476-9. Epub 2021 Apr 16. BioDrugs. 2021. PMID: 33860919 Free PMC article. No abstract available.
References
-
- Tanni KA, Truong CB, Almahasis S, Qian J. Safety of marketed cancer supportive care biosimilars in the US: a disproportionality analysis using the food and drug administration adverse event reporting system (FAERS) database. BioDrugs. 2021. https://doi.org/10.1007/s40259-020-00466-3 . - DOI - PubMed
-
- Putzke J, Haughie S, Zou KH, Ranganna GM. Comment on: “Safety of marketed cancer supportive care biosimilars in the US: a disproportionality analysis using the food and drug administration adverse event reporting system (FAERS) Database”. BioDrugs. 2021. https://doi.org/10.1007/s40259-021-00476-9 . - DOI - PubMed
-
- U.S. Food and Drug Administration. Questions and Answers on FDA's Adverse Event Reporting System (FAERS). https://www.fda.gov/drugs/surveillance/questions-and-answers-fdas-advers... . Accessed 19 Feb 2021.
-
- U.S. Food and Drug Administration. FAERS Reporting by Patient Outcomes by Year. https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-repor... . Accessed 19 Feb 2021.
-
- Fukazawa C, Hinomura Y, Kaneko M, Narukawa M. Significance of data mining in routine signal detection: analysis based on the safety signals identified by the FDA. Pharmacoepidemiol Drug Saf. 2018;27(12):1402–8. https://doi.org/10.1002/pds.4672 . - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
